Strontium Cation Sr-89: Side Effects, Uses & Monitoring
STRONTIUM CHLORIDE Sr-89 INJECTION, USP is indicated for the relief of bone pain in patients with painful skeletal metastases.
- Data source
- FDA labeling via NIH DailyMed (label c89bcf16…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
STRONTIUM CHLORIDE Sr-89 INJECTION, USP is indicated for the relief of bone pain in patients with painful skeletal metastases. The presence of bone metastases should be confirmed prior to therapy.
Frequently Asked Questions
What is Strontium Cation Sr-89 used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Strontium Cation Sr-89?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Strontium Cation Sr-89 require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Strontium Cation Sr-89.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.